Csenge Advisory Group Ligand Pharmaceuticals Inc Call Options Transaction History
Csenge Advisory Group
- $1.81 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$390 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$279 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$140 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$123 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$101 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.29B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...